Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Revenues Up, Earnings Down in Q1

NEW YORK, May 3 (GenomeWeb News) - Beckman Coulter reported increased revenues but smaller earnings for the first quarter of 2004 today.

 

The company had $536.8 million in revenues, up from $467.3 million during the first quarter last year.

 

R&D expenses increased to $48.1 million, from $45.5 million during the same period in 2003.

 

Net earnings decreased to $35.6 million, or $.57 per share, down from $44.6 million, or $.73 per share, during the first quarter last year.

 

As of March 31, Beckman had $49 million in cash and cash equivalents.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.